Waco, TX-based Baylor University, Pennsylvania’s University of Pittsburgh, and Ohio’s University of Cincinnati have joined biopharmaceutical research and medical device company Chicago, IL-based CytoCore’s current clinical trial of the e2 Collector, a medical device for detecting and treating reproductive-tract cancers.
